Atara Biotherapeutics (ATRA) Receivables - Net (2020 - 2026)
Atara Biotherapeutics' Receivables - Net was $318,000 in Q2 2026.
Analysis
Atara Biotherapeutics (ATRA) Receivables - Net (2020 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Atara Biotherapeutics came in at $1.25 million, down 15.5% from FY2024.
- Receivables - Net has now declined for three consecutive years, with a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- In earlier years, Receivables - Net was $1.48 million in FY2024 (-95.7%), $34.11 million in FY2023 (-15.2%), $40.22 million in FY2022 and $986,000 in FY2021 (-21.1%).
- The Q2 2026 figure marks the lowest quarterly Receivables - Net since Q3 2023.
- Compared with a year earlier, Receivables - Net was higher in two of the last five quarters, with growth averaging 115.2%.
- The best year-over-year quarter for Receivables - Net over five years was Q3 2024 (growth of 719.0%); the worst was Q4 2024 (a decline of 95.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Atara Biotherapeutics | 141.16 Mn | 131.26 Mn | 439,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 318,000.00 |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 8.88 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | 35.83 Mn |
| Dec 31, 2023 | 34.11 Mn |
| Sep 30, 2023 | 163,000.00 |
| Jun 30, 2023 | 507,000.00 |
| Mar 31, 2023 | 397,000.00 |
| Dec 31, 2022 | 40.22 Mn |
| Sep 30, 2022 | 249,000.00 |
| Jun 30, 2022 | 637,000.00 |
| Mar 31, 2022 | 668,000.00 |
| Dec 31, 2021 | 986,000.00 |
| Mar 31, 2021 | 9.61 Mn |
| Dec 31, 2020 | 1.25 Mn |
API Access
Atara Biotherapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ATRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();